{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:38:39Z","timestamp":1789785519988,"version":"4.0.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":457,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1111\/bjd.12972","type":"journal-article","created":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T21:38:40Z","timestamp":1395178720000},"page":"1341-1349","source":"Crossref","is-referenced-by-count":83,"title":["Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study"],"prefix":"10.1093","volume":"170","author":[{"given":"A.J.","family":"Kanwar","sequence":"first","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Vinay","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.U.","family":"Sawatkar","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dogra","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.W.","family":"Minz","sequence":"additional","affiliation":[{"name":"Department of Immunopathology; Postgraduate Institute of Medical Education and Research; Chandigarh 160012 India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.H.","family":"Shear","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Sunnybrook Health Sciences Centre; University of Toronto; Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Koga","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Kurume University School of Medicine; Kurume University Institute of Cutaneous Cell Biology; 67 Asahimachi Kurume Fukuoka 830-0011 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Kurume University School of Medicine; Kurume University Institute of Cutaneous Cell Biology; 67 Asahimachi Kurume Fukuoka 830-0011 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Kurume University School of Medicine; Kurume University Institute of Cutaneous Cell Biology; 67 Asahimachi Kurume Fukuoka 830-0011 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,6,19]]},"reference":[{"key":"10.1111\/bjd.12972-BIB0001|bjd12972-cit-0001","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1749-6632.2009.04744.x","article-title":"Rituximab in severe pemphigus","volume":"1173","author":"Schmidt","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/bjd.12972-BIB0002|bjd12972-cit-0002","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1111\/j.1468-3083.2011.04391.x","article-title":"Efficacy and safety of rituximab treatment in Indian pemphigus patients","volume":"27","author":"Kanwar","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.12972-BIB0003|bjd12972-cit-0003","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jaad.2011.12.019","article-title":"Rituximab treatment of severe pemphigus: long-term results including immunologic follow-up","volume":"67","author":"Reguiai","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12972-BIB0004|bjd12972-cit-0004","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.jaad.2010.06.033","article-title":"Rituximab used as a first-line single agent in the treatment of pemphigus vulgaris","volume":"65","author":"Craythorne","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12972-BIB0005|bjd12972-cit-0005","first-page":"622","article-title":"Where does rituximab fit in the treatment of autoimmune mucocutaneous blistering skin disease?","volume":"11","author":"Nigam","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.12972-BIB0006|bjd12972-cit-0006","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4103\/0378-6323.102354","article-title":"Rituximab in pemphigus","volume":"78","author":"Kanwar","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/bjd.12972-BIB0007|bjd12972-cit-0007","first-page":"1200","article-title":"Is it time to re-evaluate the treatment of pemphigus?","volume":"11","author":"Leventhal","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.12972-BIB0008|bjd12972-cit-0008","doi-asserted-by":"crossref","first-page":"632","DOI":"10.4103\/0378-6323.100587","article-title":"Childhood pemphigus vulgaris successfully treated with rituximab","volume":"78","author":"Kanwar","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/bjd.12972-BIB0009|bjd12972-cit-0009","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000287254","article-title":"Rituximab in childhood pemphigus vulgaris: a long-term follow-up case and review of the literature","volume":"221","author":"Fuertes","year":"2010","journal-title":"Dermatology"},{"key":"10.1111\/bjd.12972-BIB0010|bjd12972-cit-0010","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2133.2005.06740.x","article-title":"Long-standing remission of recalcitrant juvenile pemphigus vulgaris after adjuvant therapy with rituximab","volume":"153","author":"Schmidt","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12972-BIB0011|bjd12972-cit-0011","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa067752","article-title":"A single cycle of rituximab for the treatment of severe pemphigus","volume":"357","author":"Joly","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.12972-BIB0012|bjd12972-cit-0012","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-2133.2007.07800.x","article-title":"Rituximab in the adjuvant treatment of pemphigus vulgaris: a prospective open-label pilot study in five patients","volume":"156","author":"Goh","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12972-BIB0013|bjd12972-cit-0013","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archderm.143.8.1033","article-title":"Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature","volume":"143","author":"Cianchini","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12972-BIB0014|bjd12972-cit-0014","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jaad.2011.11.007","article-title":"Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up","volume":"67","author":"Cianchini","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12972-BIB0015|bjd12972-cit-0015","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/art.21778","article-title":"The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial","volume":"54","author":"Emery","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1111\/bjd.12972-BIB0016|bjd12972-cit-0016","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1093\/rheumatology\/keq116","article-title":"Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)","volume":"49","author":"Rubbert-Roth","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/bjd.12972-BIB0017|bjd12972-cit-0017","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2133.2011.10663.x","article-title":"Low-dose rituximab is effective in pemphigus","volume":"166","author":"Horvath","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12972-BIB0018|bjd12972-cit-0018","article-title":"Clinical experiences of different dosing schedules of rituximab in pemphigus with various disease severities","author":"Cho","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl. 1","key":"10.1111\/bjd.12972-BIB0019|bjd12972-cit-0019","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1007\/s00403-002-0367-2","article-title":"History of the establishment and revision of diagnostic criteria, severity index and therapeutic guidelines for pemphigus in Japan","volume":"295","author":"Ikeda","year":"2003","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/bjd.12972-BIB0020|bjd12972-cit-0020","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1365-4362.2003.01811.x","article-title":"A new grading system for oral pemphigus","volume":"42","author":"Saraswat","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.12972-BIB0021|bjd12972-cit-0021","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaad.2008.01.012","article-title":"Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus","volume":"58","author":"Murrell","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12972-BIB0022|bjd12972-cit-0022","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.4049\/jimmunol.159.4.2010","article-title":"Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins","volume":"159","author":"Ishii","year":"1997","journal-title":"J Immunol"},{"key":"10.1111\/bjd.12972-BIB0023|bjd12972-cit-0023","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/rheumatology\/kel393","article-title":"Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7\u00a0yrs","volume":"46","author":"Popa","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/bjd.12972-BIB0024|bjd12972-cit-0024","first-page":"379","article-title":"Response in patients with pemphigus vulgaris to rituximab therapy. Basis of the biology of B cells","volume":"144","author":"Leuci","year":"2009","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1111\/bjd.12972-BIB0025|bjd12972-cit-0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2165\/11596370-000000000-00000","article-title":"A guide to rational dosing of monoclonal antibodies","volume":"51","author":"Bai","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/bjd.12972-BIB0026|bjd12972-cit-0026","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/0091270005277075","article-title":"Population pharmacokinetics of rituximab (anti-CD20 monoclonal antibody) in rheumatoid arthritis patients during a phase II clinical trial","volume":"45","author":"Ng","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/bjd.12972-BIB0027|bjd12972-cit-0027","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jaad.2012.08.010","article-title":"Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: a retrospective study of 47 patients","volume":"68","author":"Leshem","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12972-BIB0028|bjd12972-cit-0028","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.clindermatol.2011.03.014","article-title":"Current therapy of the pemphigus group","volume":"30","author":"Kasperkiewicz","year":"2012","journal-title":"Clin Dermatol"},{"key":"10.1111\/bjd.12972-BIB0029|bjd12972-cit-0029","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/exd.12331","article-title":"The need for markers and predictors of Rituximab treatment resistance","volume":"23","author":"Sitaru","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.12972-BIB0030|bjd12972-cit-0030","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1177\/0091270007305297","article-title":"Rituximab pharmacokinetics in patients with rheumatoid arthritis: B-cell levels do not correlate with clinical response","volume":"47","author":"Breedveld","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/bjd.12972-BIB0031|bjd12972-cit-0031","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2133.2011.10658.x","article-title":"Comparison of immunological parameters in patients with pemphigus vulgaris following rituximab and IVIG therapy","volume":"166","author":"Feldman","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12972-BIB0032|bjd12972-cit-0032","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archdermatol.2009.9","article-title":"ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus","volume":"145","author":"Abasq","year":"2009","journal-title":"Arch Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.12972","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.12972\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T04:52:56Z","timestamp":1689051176000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/170\/6\/1341\/6614682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.12972","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718314335.793493271","asserted-by":"object"}]},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}